✨ Medicines Consents and Appointment




3876 NEW ZEALAND GAZETTE, No. 161 5 NOVEMBER 2009

Product: Macleans Advanced Mild Mint
Active Ingredient: Sodium fluoride 0.3152%w/w
Dosage Form: Toothpaste
New Zealand Sponsor: GlaxoSmithKline (NZ) Limited
Manufacturer: GlaxoSmithKline Consumer Healthcare, Maidenhead, Berkshire, United Kingdom

Dated this 30th day of October 2009.

MARK RICHARDS, Acting Deputy Director-General, Sector Accountability and Funding Directorate, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).

go9095

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Product: Efavirenz - Rex
Active Ingredient: Efavirenz 600mg
Dosage Form: Film coated tablet
New Zealand Sponsor: REX Medical Limited
Manufacturer: Cipla Limited, Manufacturing Division, Verna, Salcette, Goa, India

Product: Innovacon hCG One Step Pregnancy Test Device
Active Ingredients: Goat anti-hcg Polyclonal antibody
Mouse anti-hcg monoclonal antibody
Dosage Form: Pregnancy test kit
New Zealand Sponsor: Inverness Medical Innovations New Zealand Limited
Manufacturers: Abon Biopharm (Hangzhou) Co., Limited, Hangzhou, China
Innovacon Inc., San Diego, California, United States of America

Product: Velcade
Active Ingredient: Bortezomib 1mg
Dosage Form: Powder for injection
New Zealand Sponsor: Janssen-Cilag (New Zealand) Limited
Manufacturer: Ben Venue Laboratories Inc, Bedford, Ohio, United States of America

Dated this 30th day of October 2009.

MARK RICHARDS, Acting Deputy Director-General, Sector Accountability and Funding Directorate, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).

go9094

Renewal of Provisional Consent to the Distribution of a Medicine

Pursuant to section 23(4A) of the Medicines Act 1981, the Minister of Health hereby renews the provisional consent to the sale, supply or use in New Zealand of the medicine set out in the Schedule hereto:

Schedule

Product: Fabrazyme
Active Ingredient: Agalsidase beta 5.5mg
Dosage Form: Powder for infusion concentrate
New Zealand Sponsor: Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
Manufacturer: Genzyme Corporation, Allston, Massachusetts, United States of America

Note: This consent is valid for two years from the date of publication of this notice.

Dated this 30th day of October 2009.

MARK RICHARDS, Acting Deputy Director-General, Sector Accountability and Funding Directorate, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).

go9103

New Zealand Public Health and Disability Act 2000

Appointment to the Perinatal and Maternal Mortality Review Committee

Pursuant to section 11 of the New Zealand Public Health and Disability Act 2000, I appoint

Dr Beverley Lawton

as a member of the Perinatal and Maternal Mortality Review Committee for a three-year term of office commencing on the date of this notification.

Dated at Wellington this 29th day of October 2009.

HON TONY RYALL, Minister of Health.

go9162



Next Page →



Online Sources for this page:

Gazette.govt.nz PDF NZ Gazette 2009, No 161





✨ LLM interpretation of page content

πŸ₯ Consent to the Distribution of Macleans Advanced Mild Mint

πŸ₯ Health & Social Welfare
30 October 2009
Medicines, Consent, Distribution, Toothpaste, Sodium fluoride
  • Mark Richards, Acting Deputy Director-General, Sector Accountability and Funding Directorate, Ministry of Health

πŸ₯ Consent to the Distribution of New Medicines

πŸ₯ Health & Social Welfare
30 October 2009
Medicines, Consent, Distribution, Efavirenz, Innovacon hCG One Step Pregnancy Test Device, Velcade
  • Mark Richards, Acting Deputy Director-General, Sector Accountability and Funding Directorate, Ministry of Health

πŸ₯ Renewal of Provisional Consent to the Distribution of Fabrazyme

πŸ₯ Health & Social Welfare
30 October 2009
Medicines, Renewal, Provisional Consent, Fabrazyme
  • Mark Richards, Acting Deputy Director-General, Sector Accountability and Funding Directorate, Ministry of Health

πŸ₯ Appointment to the Perinatal and Maternal Mortality Review Committee

πŸ₯ Health & Social Welfare
29 October 2009
Appointment, Perinatal and Maternal Mortality Review Committee
  • Beverley Lawton (Dr), Appointed member of the Perinatal and Maternal Mortality Review Committee

  • Hon Tony Ryall, Minister of Health